nach oben

Erschienen in:

01.12.2011 | Original Paper

Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression

Erschienen in: Medical Oncology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The centrosome-associated kinase aurora A (AURKA) has been shown to be involved in genetic instability and to be over-expressed in several human carcinomas including gastric cancers (GCs). The chromosome locus of AURKA, 20q13, is frequently amplified in GCs, and the functional impact of such regions needs to be extensively investigated in large amount of clinical samples. Case-matched tissues of gastric carcinomas and adjacent normal epithelium (n = 141) were included in this study. Quantitative PCR was carried out to examine the copy number and mRNA expression of AURKA in GCs. Our results showed copy-number gains of AUKRA were detected in a relative high percentage of GC samples (30.5%, 43 out of 141). There was a positive correlation between copy-number increase of AURKA and tumor progression. And copy-number gains of AURKA also showed a positive correlation with mRNA over-expression in GCs. However, expression level of AURKA mRNA was also enhanced in the group of GC samples with unaltered copy numbers. These findings indicated that sporadic gastric cancers exhibit different mechanisms of AURKA regulation and that this may impact the efficacy of aurora-targeted therapies.

Goepfert TM, Brinkley BR. The centrosome-associated aurora/ipl-like kinase family. Curr Top Dev Biol. 2000;49:331–42.PubMedCrossRef

Kimura M, Okano Y. Aurora kinases and cancer. Gan To Kagaku Ryoho. 2005;32:1–5.PubMed

Ikezoe T. Aurora kinases as an anti-cancer target. Cancer Lett. 2008;262(1):1–9.PubMedCrossRef

Kamada K, Yamada Y, Hirao T, Fujimoto H, Takahama Y, et al. Amplification/overexpression of aurora-a in human gastric carcinoma. Potential role in differentiated type gastric carcinogenesis. Oncol Rep. 2004;12:593–9.PubMed

Dar AA, Zaika A, Piazuelo MB, Correa P, Koyama T, et al. Frequent overexpression of aurora kinase a in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer. 2008;112:1688–98.PubMedCrossRef

Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, et al. Quantitation of aurora kinase a gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst. 2008;100:1401–11.PubMedCrossRef

Andrews J, Kennette W, Pilon J, Hodgson A, Tuck AB, et al. Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number. PLoS One. 2010;5:e8665.PubMedCrossRef

Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009;459:987–91.PubMedCrossRef

Liu W, Sun J, Li G, Zhu Y, Zhang S, et al. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res. 2009;69:2176–9.PubMedCrossRef

10.

Buffart TE, van Grieken NC, Tijssen M, Coffa J, Ylstra B, et al. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch. 2009;455:213–23.PubMedCrossRef

11.

Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosom Cancer. 1999;24:299–305.PubMedCrossRef

12.

Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization. Cancer Genet Cytogenet. 2006;167:150–4.PubMedCrossRef

13.

Lam AK, Ong K, Ho YH. Aurora kinase expression in colorectal adenocarcinoma. Correlations with clinicopathological features, p16 expression, and telomerase activity. Hum Pathol. 2008;39:599–604.PubMedCrossRef

14.

Lassmann S, Danciu M, Muller M, Weis R, Makowiec F, et al. Aurora a is differentially expressed and regulated in chromosomal and microsatellite instable sporadic colorectal cancers. Mod Pathol. 2009;22:1385–97.PubMedCrossRef

15.

Kyrlagkitsis I, Karamanolis DG. Genes and gastric cancer. Hepatogastroenterology. 2004;51:320–7.PubMed

16.

Wu CW, Chi CW, Lin WC. Gastric cancer. Prognostic and diagnostic advances. Expert Rev Mol Med. 2002;4:1–12.PubMedCrossRef

17.

Kikuchi K, Ueda M, Kitajima M. Molecular biology in gastric cancer. Gan To Kagaku Ryoho. 1999;26:2139–46.PubMed

18.

Dear PH. Copy-number variation. The end of the human genome? Trends Biotechnol. 2009;27:448–54.PubMedCrossRef

19.

Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, et al. Excessive genomic DNA copy number variation in the li-fraumeni cancer predisposition syndrome. Proc Natl Acad Sci USA. 2008;105:11264–9.PubMedCrossRef

20.

Grubor V, Krasnitz A, Troge JE, Meth JL, Lakshmi B, et al. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (roma). Blood. 2009;113:1294–303.PubMedCrossRef

21.

Gunnarsson R, Staaf J, Jansson M, Ottesen AM, Goransson H, et al. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia–a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosom Cancer. 2008;47:697–711.PubMedCrossRef

22.

Schafer M, Schwender H, Merk S, Haferlach C, Ickstadt K, et al. Integrated analysis of copy number alterations and gene expression. A bivariate assessment of equally directed abnormalities. Bioinformatics. 2009;25:3228–35.PubMedCrossRef

23.

Strefford JC, van Delft FW, Robinson HM, Worley H, Yiannikouris O, et al. Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Proc Natl Acad Sci USA. 2006;103:8167–72.PubMedCrossRef

24.

Sulong S, Moorman AV, Irving JA, Strefford JC, Konn ZJ, et al. A comprehensive analysis of the cdkn2a gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood. 2009;113:100–7.PubMedCrossRef

25.

Vauhkonen H, Vauhkonen M, Sipponen P, Knuutila S. Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas. Cytogenet Genome Res. 2007;119:39–45.PubMedCrossRef

26.

Aust DE, Muders M, Kohler A, Schmidt M, Diebold J, et al. Prognostic relevance of 20q13 gains in sporadic colorectal cancers. A fish analysis. Scand J Gastroenterol. 2004;39:766–72.PubMedCrossRef

27.

Dermitzakis ET, Stranger BE. Genetic variation in human gene expression. Mamm Genome. 2006;17:503–8.PubMedCrossRef

28.

Reymond A, Henrichsen CN, Harewood L, Merla G. Side effects of genome structural changes. Curr Opin Genet Dev. 2007;17:381–6.PubMedCrossRef

29.

Guryev V, Saar K, Adamovic T, Verheul M, van Heesch SA, et al. Distribution and functional impact of DNA copy number variation in the rat. Nat Genet. 2008;40:538–45.PubMedCrossRef

30.

Henrichsen CN, Vinckenbosch N, Zollner S, Chaignat E, Pradervand S, et al. Segmental copy number variation shapes tissue transcriptomes. Nat Genet. 2009;41:424–9.PubMedCrossRef

31.

Fujita Y, Sakakura C, Shimomura K, Nakanishi M, Yasuoka R, et al. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology. 2003;50:1857–63.PubMed

32.

Agnese V, Cabibi D, Calcara D, Terrasi M, Pantuso G, et al. Aurora-a overexpression as an early marker of reflux-related columnar mucosa and barrett’s oesophagus. Ann Oncol. 2007;18(Suppl 6):vi110–5.PubMedCrossRef

33.

Tong T, Zhong Y, Kong J, Dong L, Song Y, et al. Overexpression of aurora-a contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res. 2004;10:7304–10.PubMedCrossRef

34.

Tanaka E, Hashimoto Y, Ito T, Okumura T, Kan T, et al. The clinical significance of aurora-a/stk15/btak expression in human esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11:1827–34.PubMedCrossRef

35.

Yamashita K, Igarashi H, Kitayama Y, Ozawa T, Kiyose S, et al. Chromosomal numerical abnormality profiles of gastrointestinal stromal tumors. Jpn J Clin Oncol. 2006;36:85–92.PubMedCrossRef

36.

Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of aurora-a in hepatocellular carcinoma. Clin Cancer Res. 2004;10:2065–71.PubMedCrossRef

37.

Rojanala S, Han H, Munoz RM, Browne W, Nagle R, et al. The mitotic serine threonine kinase, aurora-2, is a potential target for drug development in human pancreatic cancer. Mol Cancer Ther. 2004;3:451–7.PubMedCrossRef

38.

Zhu J, Abbruzzese JL, Izzo J, Hittelman WN, Li D. Aurka amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells. Cancer Genet Cytogenet. 2003;2005:159.10–7.

39.

Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, et al. Overexpression of oncogenic stk15/btak/aurora a kinase in human pancreatic cancer. Clin Cancer Res. 2003;9:991–7.PubMed

40.

Nishida N, Nagasaka T, Kashiwagi K, Boland CR, Goel A. High copy amplification of the aurora-a gene is associated with chromosomal instability phenotype in human colorectal cancers. Cancer Biol Ther. 2007;6:525–33.PubMedCrossRef

41.

Baba Y, Nosho K, Shima K, Irahara N, Kure S, et al. Aurora-a expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia. 2009;11:418–25.PubMed

42.

Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, et al. Tumour-amplified kinase btak is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer. 2001;84:824–31.PubMedCrossRef

Titel: Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression
Publikationsdatum: 01.12.2011
Erschienen in: Medical Oncology / Ausgabe 4/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-010-9602-4

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Epigenetic regulation of retinoic acid receptor β2 gene in the initiation of breast cancer

Multidrug resistance strength of the novel multidrug resistance gene HA117: compared with MRP1

Lingual metastasis as an initial presentation of renal cell carcinoma

MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis

Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma

Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie